BNIP3 and lung carcinoma: To explore whether p65 inhibition is a potential factor in mediating BNIP3 upregulation in CVB-D-treated lung cancer cells, we established p65 overexpression and knockdown cells to explore its roles in CVB-D-induced BNIP3 upregulation.